long-term results from a trial of tag in patients with bpdcn
Published 3 years ago • 139 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
3:54
outcomes of patients with bpdcn who recieved hsct following induction with tagraxofusp
-
4:19
outcomes of patients with bpdcn after allohsct
-
2:37
recent advances in the treatment of bpdcn & the long-term benefits of tagraxofusp
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
2:39
ligasure exact™ vs. voyant
-
5:18
how many units of ffp reverse inr in bleeding disorders? fresh frozen plasma, international normaliz
-
18:39
surprises in coagulation testing–prolonged aptt & pt case [hot topic]
-
2:43
phase i/ii trial of tagraxofusp in poor-risk myelofibrosis
-
1:40
long-term follow-up of luspatercept: response duration and progression to aml
-
2:42
results from a phase i study of cc-98633 in r/r myeloma
-
8:57
outcomes of sct in t-all and t-lbl
-
1:22
long-term follow-up results of tourmaline-mm2: ird vs pbo-rd in multiple myeloma
-
1:22
interim analysis of a study evaluating pivekimab sunirine in patients with bpdcn
-
1:25
preliminary results from a phase ib trial of as-1763, a novel non-covalent btki, in cll/mcl
-
2:42
results of phase i/ii study of epcoritamab r-dhax/c in patients with r/r dlbcl eligible for autosct
-
1:56
updated results of phase i/ii bruin study: pirtobrutinib in covalent btk inhibitor pretreated mcl
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
3:59
the challenges of treating bpdcn and the role of diagnostic markers
-
2:48
the safety and efficacy of tagraxofusp for the treatment of bpdcn
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
2:28
promising early results of a novel anti-cd123 antibody-drug conjugate in r/r bpdcn